what future for messenger RNA vaccines in 2023?
Let’s take a little step back and dive back into 2020 (if you can bear it). At that time, the more the year progressed, the more the impact of Covid-19 was felt. Different governments across the planet were recommending their fellow citizens to wear masks, disinfect everything they touch, and stay away from others. These were the only ways to protect themselves from this potentially deadly virus.
Fortunately, a more effective form of protection was being crafted. Scientists were developing new vaccines at breakneck speed. The virus that causes Covid-19 was sequenced in January and clinical trials of vaccines using messenger RNA began in March. At the end of the year, in the United States, the Food and Drug Administration issued an emergency use authorization for these vaccines. As a result, the number of vaccinations has taken off and to date more than 670 million doses of vaccines have been administered in the United States alone.
This is a surprisingly fast turnaround for a brand new drug. But it must be taken into account that this vaccine is the result of many years of research on the basic technology. Indeed, scientists and companies have been working on mRNA-based treatments and vaccines for decades. The first experimental treatments were tested on rodents in the 1990s in an attempt to find solutions to diseases such as (…)
(…) Click here to see more
Pension reform: transport unions call for a “powerful strike” on January 19
Twitter: soon “corners” to remunerate the best contributors?
Oil: prices climb despite massive inflation of US stocks
The juicy contract that PSG would offer Messi to extend
Coca-Cola, Nestlé, Barilla… Here are the food brands whose turnover increased the most in 2022
#future #messenger #RNA #vaccines